Publications by authors named "S Mersakova"

Introduction: Within oncology research, there is a high effort for new approaches to prevent and treat cancer as a life-threatening disease. Specific plant species that adapt to harsh conditions may possess unique properties that may be utilized in the management of cancer.

Hypothesis: Chokeberry fruit is rich in secondary metabolites with anti-cancer activities potentially useful in cancer prevention and treatment.

View Article and Find Full Text PDF

Here, we present newly derived in vitro model for modeling Duchenne muscular dystrophy. Our new cell line was derived by reprogramming of peripheral blood mononuclear cells (isolated from blood from pediatric patient) with Sendai virus encoding Yamanaka factors. Derived iPS cells are capable to differentiate in vitro into three germ layers as verified by immunocytochemistry.

View Article and Find Full Text PDF

Introduction: Colorectal cancer (CRC) can develop through several dysregulated molecular pathways, including the serrated pathway, characterized by CpG island methylator (CIMP) phenotype. Although the tumor tissue is a commonly tested material, sample types such as stool or plasma, bring a new, non-invasive approach. Several cancer-related methylated genes have been identified in CRC patients, including gene , showing promising diagnostic potential.

View Article and Find Full Text PDF

We present here a new iPS cell line for modeling sporadic form of ALS. Cell line was generated by reprogramming skin fibroblasts isolated with explant culture technology from skin biopsy, donated by ALS patient. For reprogramming, polycistronic self-replicating RNA vector was used and derived iPS cells were characterized by immunocytochemistry and FACS (pluripotent factors expression), karyotyping, STR fingerprinting analysis and in vitro differentiation assay.

View Article and Find Full Text PDF
Article Synopsis
  • - The incidence of colorectal cancer (CRC) has increased significantly over the last decade, leading to a focus on understanding the disease's pathology and treatment resistance, particularly linked to cancer stem cells.
  • - A study in Slovakia aimed to examine specific stem cell markers (CD133, CD166, and Lgr5) in CRC tumors using flow cytometry, as well as analyze DNA methylation of CRC biomarkers in patient samples.
  • - Results indicated that metastatic tumors had higher CD133 cell levels than primary tumors, with a correlation to CRC aggressiveness and lymphatic invasion, highlighting CD133's potential role as a key marker in CRC pathology.
View Article and Find Full Text PDF